Raman Prakash 4

What Happened

• Director Raman Prakash received 6,105 shares of Black Diamond Therapeutics common stock on March 20, 2026. The shares were issued at an effective price of $2.15 per share, for a total value of $13,126. This was an award/acquisition under the issuer’s director compensation policy (not an open‑market purchase or sale).

Key Details

• Transaction date: 2026-03-20
• Transaction type/code: Award/Grant (A)
• Shares issued: 6,105 shares at $2.15 per share; total value $13,126
• Price basis: $2.15 is the closing market price on March 19, 2026 (per footnote)
• Source/why: Issued under the Issuer’s Fifth Amended and Restated Non‑Employee Director Compensation Policy; the director elected shares in lieu of cash (footnote F1)
• Shares owned after transaction: Not reported in the Form 4 filing
• Filing timeliness: Reported on 2026-03-20 (same day as the transaction), indicating a timely filing

Context

• These shares are director compensation issued in lieu of cash and are routine for non‑employee directors. Such awards reflect compensation policy rather than a direct buy/sell market signal. They are different from open‑market purchases (which may indicate insider conviction) or sales (which can indicate liquidity needs).